One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Venous Thromboembolism in Children with Inflammatory Bowel Disease: When is the Right Time for Thromboprophylaxis?
Franco Torrente, Richard Hansen
doi : 10.1093/ecco-jcc/jjab221
Journal of Crohn's and Colitis, Volume 16, Issue 5, May 2022, Pages 691–692
Progressing Towards the Implementation of a Treat-To-Target Strategy in Perianal Crohn’s Disease
C Reenaers, E Louis
doi : 10.1093/ecco-jcc/jjab166
The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry
Martine A Aardoom, Renz C W Klomberg, Polychronis Kemos, Frank M Ruemmele, PIBD-VTE Group , C H (Heleen) van Ommen, Lissy de Ridder, Nicholas M Croft, PIBD-SETQuality Consortium
doi : 10.1093/ecco-jcc/jjab171
Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn’s Disease Patients
Kyra L van Rijn, Elise M Meima-van Praag, Patrick M Bossuyt, Geert R D’Haens, Krisztina B Gecse, Karin Horsthuis, Harmanna J Snijder, Jeroen A W Tielbeek, Christianne J Buskens, Jaap Stoker
doi : 10.1093/ecco-jcc/jjab168
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn’s Disease: Meta-Analysis of Randomised Controlled Trials
Ahmed Almradi, Rocio Sedano, Malcolm Hogan, G Y Zou, John K MacDonald, Claire E Parker, Jurij Hanzel, Eileen Crowley, Siddharth Singh, Geert D’Haens, William J Sandborn, Brian G Feagan, Christopher Ma, Vipul Jairath
doi : 10.1093/ecco-jcc/jjab194
Improving Care for Recently Diagnosed Inflammatory Bowel Disease Patients: Lessons Learned From a Patient-Centred, Mixed-Method Study
Liselot W van Erp, Myrte K Neijenhuis, Wendy Heida, Joost Derwig, Caroline E Geleijns, Marcel J M Groenen, Peter J Wahab
doi : 10.1093/ecco-jcc/jjab196
A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn’s Disease
Geert D’Haens, Silvio Danese, Martin Davies, Mamoru Watanabe, Toshifumi Hibi
doi : 10.1093/ecco-jcc/jjab201
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases – A Danish Prospective Population-Based Cohort Study with Individual-Level Data
Mohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, Malte Rosager Hansen, Marianne Kajbæk Vester-Andersen, Sule Eraslan, August Pilegaard Prahm, Natalia Pedersen, Lone Larsen, Tine Jess, Anders Neumann, Kent V Haderslev, Akbar Molazahi, Anders Berg Lødrup, Henning Glerup, Asser Mathiassen Oppfeldt, Michael Dam Jensen, Klaus Theede, Marianne Kiszka-Kanowitz, Jakob Benedict Seidelin, Johan Burisch
doi : 10.1093/ecco-jcc/jjab192
Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease
Maribeth R Nicholson, Erin Alexander, Sonia Ballal, Zev Davidovics, Michael Docktor, Michael Dole, Jonathan M Gisser, Alka Goyal, Suchitra K Hourigan, M Kyle Jensen, Jess L Kaplan, Richard Kellermayer, Judith R Kelsen, Melissa A Kennedy, Sahil Khanna, Elizabeth D Knackstedt, Jennifer Lentine, Jeffery D Lewis, Sonia Michail, Paul D Mitchell, Maria Oliva-Hemker, Tiffany Patton, Karen Queliza, Sarah Sidhu, Aliza B Solomon, David L Suskind, Madison Weatherly, Steven Werlin, Edwin F de Zoeten, Stacy A Kahn, North American Society of Pediatric Gastroenterology and Nutrition Faecal Microbiota Transplantation Special Interest Group
doi : 10.1093/ecco-jcc/jjab202
Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, Natan Ledderman, Shira Greenfeld, Revital Kariv, Saleh Daher, Henit Yanai, Yiska Loewenberg Weisband, Hagit Gabay, Eran Matz, Daniel Nevo, Eran Israeli, Doron Schwartz, Yehuda Chowers, Iris Dotan, Dan Turner
doi : 10.1093/ecco-jcc/jjab204
Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN
Ohad Atia, Sasha Harel, Natan Ledderman, Shira Greenfeld, Revital Kariv, Iris Dotan, Ran Balicer, Barbara Silverman, Eran Matz, Zohar Levi, Matti Waterman, Iris Fried, Jacob M Rowe, Dan Turner
doi : 10.1093/ecco-jcc/jjab205
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, Natan Ledderman, Shira Greenfeld, Revital Kariv, Saleh Daher, Henit Yanai, Yiska Loewenberg Weisband, Hagit Gabay, Eran Matz, Daniel Nevo, Jacob Ollech, Eran Zittan, Eran Israeli, Doron Schwartz, Yehuda Chowers, Iris Dotan, Dan Turner
doi : 10.1093/ecco-jcc/jjab210
Paediatric Ulcerative Colitis Is a Fibrotic Disease and Is Linked with Chronicity of Inflammation
Ilyssa O Gordon, Suha Abushamma, Jacob A Kurowski, Stefan D Holubar, Lei Kou, Ruishen Lyu, Florian Rieder
doi : 10.1093/ecco-jcc/jjab216
Anogenital Crohn’s Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and Treatment
Sailish Honap, Susanna Meade, Ashley Spencer, Polychronis Pavlidis, Raphael P Luber, Eduardo Calonje, Ellie Rashidghamat, Christopher B Bunker, Fiona Lewis, Peter M Irving
doi : 10.1093/ecco-jcc/jjab211
Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
Ferdinando D’Amico, Fernando Magro, Laurent Peyrin-Biroulet, Silvio Danese
doi : 10.1093/ecco-jcc/jjab206
Inflammatory Bowel Diseases Benefit from Enhanced Recovery After Surgery [ERAS] Protocol: A Systematic Review with Practical Implications
Vincenzo Vigorita, Oscar Cano-Valderrama, Valerio Celentano, Danilo Vinci, Monica Millán, Antonino Spinelli, Gianluca Pellino
doi : 10.1093/ecco-jcc/jjab209
Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras, Stergios A Polyzos
doi : 10.1093/ecco-jcc/jjab212
Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
Péter Bacsur, Klaudia Farkas, Tamás Molnar
doi : 10.1093/ecco-jcc/jjab207
Sleeve Gastrectomy in Patients with Inflammatory Bowel Disease Is Not Associated with Worsening Disease
Rachit Gupta, Michael MacIsaac, Emily Kate Wright
doi : 10.1093/ecco-jcc/jjab195
Management of Pregnant Women with Inflammatory Bowel Disease and COVID-19–Balancing Risks of Delayed Treatment Recommencement
Ralley E Prentice, Alyson L Ross, Emma K Flanagan
doi : 10.1093/ecco-jcc/jjab214
